NAVIGATING ANTIBODY-DRUG CONJUGATE TARGETS EXPRESSION PROFILES ACROSS DIVERSE PROSTATE CANCER TYPES

被引：0
|
作者：
Mulati, Yelin
Fan, Yu
Tian, Yuxuan
Yao, Kaifeng
Shen, Qi
Yu, Wei
Zhang, Qian
He, Zhisong
机构：
来源：
JOURNAL OF UROLOGY | 2024年 / 211卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD42-09
引用
收藏
页码：E896 / E896
页数：1
相关论文
共 50 条
  • [31] Discovery of a novel highly specific, fully human PSCA antibody and its application as an antibody-drug conjugate in prostate cancer
    Chu, Xiaojie
    Shin, Seungmin
    Baek, Du-San
    Zhang, Liyong
    Conard, Alex
    Shi, Megan
    Kim, Ye-Jin
    Adams, Cynthia
    Hines, Maggie
    Liu, Xianglei
    Chen, Chuan
    Sun, Zehua
    Jelev, Dontcho V.
    Mellors, John W.
    Dimitrov, Dimiter S.
    Li, Wei
    MABS, 2024, 16 (01)
  • [32] Future potential targets of antibody-drug conjugates in breast cancer
    Corti, Chiara
    Bielo, Luca Boscolo
    Schianca, Ambra Carnevale
    Salimbeni, Beatrice Taurelli
    Criscitiello, Carmen
    Curigliano, Giuseppe
    BREAST, 2023, 69 : 312 - 322
  • [33] Sequential use of antibody-drug conjugate after antibody-drug conjugate for patients with metastatic breast cancer: ADC after ADC (A3) study
    Abelman, Rachel Occhiogrosso
    Spring, Laura
    Fell, Geoffrey G.
    Ryan, Phoebe
    Vidula, Neelima
    Medford, Arielle J.
    Shin, Jennifer
    Isakoff, Steven J.
    Moy, Beverly
    Ellisen, Leif W.
    Bardia, Aditya
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [34] Antibody-drug conjugate targeting tissue factor for pancreatic cancer treatment
    Tsumura, Ryo
    Anzai, Takahiro
    Manabe, Shino
    Takashima, Hiroki
    Koga, Yoshikatsu
    Yasunaga, Masahiro
    Matsumura, Yasuhiro
    CANCER SCIENCE, 2021, 112 : 725 - 725
  • [35] Strategies and Advancement in Antibody-Drug Conjugate Optimization for Targeted Cancer Therapeutics
    Kim, Eunhee G.
    Kim, Kristine M.
    BIOMOLECULES & THERAPEUTICS, 2015, 23 (06) : 493 - 509
  • [36] Computational Approaches in Antibody-drug Conjugate Optimization for Targeted Cancer Therapy
    Melo, Rita
    Lemos, Agostinho
    Preto, Antonio J.
    Almeida, Jose G.
    Correia, Joao D. G.
    Sensoy, Ozge
    Moreira, Irina S.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2018, 18 (13) : 1091 - 1109
  • [37] Current Landscape of Antibody-Drug Conjugate Development in Head and Neck Cancer
    Park, Jong Chul
    Shin, Donghoon
    JCO PRECISION ONCOLOGY, 2024, 8
  • [38] Research Progress of Antibody-Drug Conjugate Therapy for Advanced Gastric Cancer
    Wang, Na
    Mei, Qingyun
    Wang, Ziwei
    Zhao, Lu
    Zhang, Dou
    Liao, Dongying
    Zuo, Jinhui
    Xie, Hongxia
    Jia, Yingjie
    Kong, Fanming
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [39] Analysis of mRNA expression profiles of 4332 drug targets across 68 major cancer types: a new bioinformatic method to predict dependency of tumors on drug targets
    Mpindi, John
    Sara, Henri
    Kilpinen, Sami
    Pisto, Tommi
    Bucher, Elmar
    Ojala, Kalle
    Iljin, Kristiina
    Haapa-Paananen, Saija
    Heikki, Joensuu
    Nees, Mathias
    Kallioniemi, Olli
    CANCER RESEARCH, 2009, 69
  • [40] A Traceless Vascular-Targeting Antibody-Drug Conjugate for Cancer Therapy
    Bernardes, Goncalo J. L.
    Casi, Giulio
    Truessel, Sabrina
    Hartmann, Isabelle
    Schwager, Kathrin
    Scheuermann, Joerg
    Neri, Dario
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2012, 51 (04) : 941 - 944
12345